Xiaoju Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
Papers in
-
- Protein Degradation and Inhibitors 6
- Cancer-related gene regulation 5
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 4
-
- Prostate Cancer Treatment and Research 10
- Co-authors
- Arul M. Chinnaiyan (13 shared papers)Xuhong Cao (7 shared papers)Irfan A. Asangani (4 shared papers)Xiaojun Jing (3 shared papers)John T. Wei (2 shared papers)Sooryanarayana Varambally (5 shared papers)Felix Y. Feng (4 shared papers)Kenneth J. Pienta (3 shared papers)
- Journals
- Cancer Research (5 papers)Scientific Reports (2 papers)Nature (2 papers)EBioMedicine (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoju Wang
46 papers receiving 3.7k citations
Xiaoju Wang's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 1.2k
- Molecular Biology 2.8k
- Pulmonary and Respiratory Medicine 935
- Radiology, Nuclear Medicine and Imaging 598
- Hematology 250
Countries citing papers authored by Xiaoju Wang
This map shows the geographic impact of Xiaoju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoju Wang more than expected).
Fields of papers citing papers by Xiaoju Wang
This network shows the impact of papers produced by Xiaoju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoju Wang. The network helps show where Xiaoju Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoju Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression Hit paper breakdown → | 2011 | 815 |
| 2 | Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer Hit paper breakdown → | 2014 | 737 |
| 3 | 2005 | 467 | |
| 4 | 2007 | 251 | |
| 5 | 2006 | 165 | |
| 6 | 2019 | 160 | |
| 7 | 2014 | 119 | |
| 8 | 2011 | 118 | |
| 9 | 2019 | 109 | |
| 10 | 2004 | 90 | |
| 11 | 2017 | 78 | |
| 12 | 2007 | 73 | |
| 13 | 2006 | 55 | |
| 14 | 2019 | 49 | |
| 15 | 2020 | 46 | |
| 16 | 2008 | 44 | |
| 17 | 2016 | 43 | |
| 18 | 2017 | 43 | |
| 19 | 2006 | 37 | |
| 20 | 2019 | 33 |
About Xiaoju Wang
Xiaoju Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 49 papers that have together received 3.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Protein Degradation and Inhibitors (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (5 papers), Ubiquitin and proteasome pathways (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.8k citations), Pulmonary and Respiratory Medicine (935 citations), Radiology, Nuclear Medicine and Imaging (598 citations) and Hematology (250 citations). Xiaoju Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Arul M. Chinnaiyan, Xuhong Cao, Irfan A. Asangani, Xiaojun Jing, John T. Wei, Sooryanarayana Varambally, Felix Y. Feng, Kenneth J. Pienta, Qi Cao and Debashis Ghosh. Their work appears in journals such as Cancer Research, Scientific Reports, Nature, EBioMedicine and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.